Enjoy Interactive Tools and Indicators
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
| Mammen Mathai | SVP, Research & Early Clin Dev | Feb 20 | Sale | 22.14 | 7,000 | 154,980 | 212,976 | Feb 22 07:03 PM |
| Mammen Mathai | SVP, Research & Early Clin Dev | Jan 11 | Option Exercise | 3.10 | 14,510 | 44,981 | 220,438 | Jan 14 07:04 PM |
| Mammen Mathai | SVP, Research & Early Clin Dev | Nov 14 | Option Exercise | 3.10 | 5,161 | 15,999 | 210,802 | Nov 16 07:01 PM |
| Mammen Mathai | SVP, Research & Early Clin Dev | Nov 02 | Sale | 21.45 | 7,000 | 150,162 | 205,641 | Nov 06 07:01 PM |
| Aguiar Michael W | Sr VP, Chief Financial Officer | Aug 27 | Sale | 27.33 | 20,561 | 561,855 | 132,486 | Aug 28 07:01 PM |
| Aguiar Michael W | Sr VP, Chief Financial Officer | Aug 24 | Option Exercise | 17.91 | 4,121 | 73,807 | 157,168 | Aug 28 07:01 PM |
| Brinkley David L | Head of Business Dev. | Aug 24 | Sale | 27.50 | 3,483 | 95,783 | 60,241 | Aug 28 07:02 PM |
| Aguiar Michael W | Sr VP, Chief Financial Officer | Aug 24 | Sale | 28.01 | 4,121 | 115,429 | 153,047 | Aug 28 07:01 PM |
| Mammen Mathai | SVP, Research & Early Clin Dev | Aug 13 | Sale | 25.74 | 25,000 | 643,461 | 212,285 | Aug 15 07:05 PM |
| Aguiar Michael W | Sr VP, Chief Financial Officer | Aug 07 | Option Exercise | 16.25 | 60,000 | 975,000 | 217,924 | Aug 09 07:00 PM |